Skip to Main Content

Author Details

Arvind Singh Mer
University of Ottawa
2011
24
12
PMIDPaper TitleJournal TitlePublished Year
37883228Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.Cell Rep2023
37847590Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.Cell Rep2023
37883228Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.Cell Rep2023
37792528Spatiotemporal modeling of chemoresistance evolution in breast tumors uncovers dependencies on SLC38A7 and SLC46A1.Cell Rep2023
37847590Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.Cell Rep2023
37792528Spatiotemporal modeling of chemoresistance evolution in breast tumors uncovers dependencies on SLC38A7 and SLC46A1.Cell Rep2023
34850112PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.Nucleic Acids Res2022
35536872Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity.Cancer Res2022
34911733Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.Cancer Discov2022
34850112PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.Nucleic Acids Res2022
35536872Bimodal Gene Expression in Patients with Cancer Provides Interpretable Biomarkers for Drug Sensitivity.Cancer Res2022
34911733Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.Cancer Discov2022
33417860Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.Cell2021
33594052Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.Nat Commun2021
34136128Highlights from the 16th International Society for Computational Biology Student Council Symposium 2020.F1000Res2021
33417860Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.Cell2021
34616866Novel subtypes of <i>NPM1</i>-mutated AML with distinct outcome.Mol Cell Oncol2021
34788078Assessing therapy response in patient-derived xenografts.Sci Transl Med2021
34382071Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models.Brief Bioinform2021
33594052Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.Nat Commun2021
34616866Novel subtypes of <i>NPM1</i>-mutated AML with distinct outcome.Mol Cell Oncol2021
34382071Drug sensitivity prediction from cell line-based pharmacogenomics data: guidelines for developing machine learning models.Brief Bioinform2021
34788078Assessing therapy response in patient-derived xenografts.Sci Transl Med2021
34136128Highlights from the 16th International Society for Computational Biology Student Council Symposium 2020.F1000Res2021
31694835Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.Clin Cancer Res2020
31694835Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.Clin Cancer Res2020
31142512Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts.Cancer Res2019
31142512Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts.Cancer Res2019
29625580Expression levels of long non-coding RNAs are prognostic for AML outcome.J Hematol Oncol2018
29625580Expression levels of long non-coding RNAs are prognostic for AML outcome.J Hematol Oncol2018
29378962Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.Proc Natl Acad Sci U S A2018
29378962Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.Proc Natl Acad Sci U S A2018
29092936Software for the Integration of Multiomics Experiments in Bioconductor.Cancer Res2017
29057710Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.Pharmacogenomics2017
29092936Software for the Integration of Multiomics Experiments in Bioconductor.Cancer Res2017
28167833Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.Leukemia2017
28167833Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.Leukemia2017
29057710Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.Pharmacogenomics2017
26830453Study design requirements for RNA sequencing-based breast cancer diagnostics.Sci Rep2016
26830453Study design requirements for RNA sequencing-based breast cancer diagnostics.Sci Rep2016
25883154CellWhere: graphical display of interaction networks organized on subcellular localizations.Nucleic Acids Res2015
25883154CellWhere: graphical display of interaction networks organized on subcellular localizations.Nucleic Acids Res2015
25889572mBISON: Finding miRNA target over-representation in gene lists from ChIP-sequencing data.BMC Res Notes2015
25889572mBISON: Finding miRNA target over-representation in gene lists from ChIP-sequencing data.BMC Res Notes2015
24283794A novel approach for protein subcellular location prediction using amino acid exposure.BMC Bioinformatics2013
24283794A novel approach for protein subcellular location prediction using amino acid exposure.BMC Bioinformatics2013
22114691MicroRNAs modulate the dynamics of the NF-κB signaling pathway.PLoS One2011
22114691MicroRNAs modulate the dynamics of the NF-κB signaling pathway.PLoS One2011
  • 1 - 48 of 48

Recommended Authors

Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 0
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 2
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 0
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 1
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 0
Gabriela Alexe
Dana-Farber Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
Adam A Margolin
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Laura Riva
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 2
Jonathan R Dry
Present Address: Tempus Labs Inc.
Career Start Year 2003
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 0
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 2
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 12
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 3
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 1
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 1
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 4
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 8
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Pablo Tamayo
University of California San Diego
Career Start Year 1988
Number of shared co-authors 3
Thomas Risch
Max Planck Institute for Molecular Genetics
Career Start Year 1976
Number of shared co-authors 5

Collaborators

Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 14
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers 5
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers 4
Daniel Klevebring
Karolinska Institutet
Co-authored papers 3
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 3
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 3
Jason Moffat
University of Toronto
Co-authored papers 2
Rama Khokha
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers 2
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers 2
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Razqallah Hakem
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Johan Lindberg
Karolinska Institute
Co-authored papers 2
Kevin R Brown
College Street, University of Toronto
Co-authored papers 2
Pirashaanthy Tharmapalan
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 2
Anna Goldenberg
SickKids Research Institute
Co-authored papers 2
Miguel A Andrade-Navarro
Institute of Organismic and Molecular Evolution, Johannes Gutenberg University
Co-authored papers 2
Hal K Berman
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Azfar Basunia
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Andrew J Elia
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 1
Vibha Raghavan
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Marcel Ramos
Graduate School of Public Health and Health Policy, City University of New York
Co-authored papers 1
Nadeem Moghal
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Miguel Ramalho-Santos
University of Toronto
Co-authored papers 1
Lucas Schiffer
Boston University
Co-authored papers 1
Markus Riester
Novartis Institutes for BioMedical Research
Co-authored papers 1
Martin Morgan
Roswell Park Comprehensive Cancer Center
Co-authored papers 1
Linda Z Penn
University of Toronto
Co-authored papers 1
Levi Waldron
City University of New York School of Public Health
Co-authored papers 1
Release 1.2